| Saham Diterbitkan | 495,092 shares |
| Saham Orang Dalam | 6,134,937 shares |
| Jumlah Orang Dalam | 22 |
Skor Sentimen Orang Dalam
Skor Sentimen Orang Dalam mendapati syarikat dibeli oleh orang dalam korporat.
Ia adalah hasil daripada model kuantitatif berbilang faktor yang canggih yang mengenal pasti syarikat dengan tahap pengumpulan orang dalam yang paling tinggi. Model pemarkahan menggunakan gabungan bilangan bersih orang dalam yang membeli 90 hari sebelumnya, jumlah saham yang dibeli sebagai peratusan saham beredar, dan jumlah saham yang dimiliki oleh orang dalam. Nombor ini berjulat dari 0 hingga 100, dengan nombor yang lebih tinggi menunjukkan tahap pengumpulan yang lebih tinggi kepada rakannya, dan 50 adalah purata.
Kekerapan Kemas Kini: Harian
Skor Sentimen Pegawai
Skor Sentimen Pegawai mendapati syarikat dibeli oleh Pegawai Korporat.
Mengikut definisi Pegawai Korporat ialah Orang Dalam Korporat, tetapi tidak seperti beberapa Orang Dalam yang lain (10% Pemegang Saham dan Ahli Lembaga), Pegawai bekerja untuk syarikat tersebut setiap hari, dan mereka menggunakan wang mereka sendiri semasa berdagang . (10% Pemegang Saham dan Ahli Lembaga Pengarah selalunya pengurus dana yang menguruskan wang orang lain.) Oleh itu, dagangan orang dalam yang dibuat oleh Pegawai adalah lebih penting dan harus dilayan dengan sewajarnya.
Seperti Skor Sentimen Orang Dalam, Skor Sentimen Pegawai adalah hasil daripada model kuantitatif berbilang faktor yang canggih yang mengenal pasti syarikat yang mempunyai tahap pengumpulan pegawai tertinggi.
Kekerapan Kemas Kini: Harian
Metrik Orang Dalam Utama
Kad ini menunjukkan bagaimana kedudukan syarikat mengikut pelbagai metrik orang dalam. Kedudukan persentil menunjukkan cara syarikat ini dibandingkan dengan syarikat lain di pasaran AS. Kedudukan yang lebih tinggi menunjukkan keadaan yang lebih baik.
Sebagai contoh, adalah diterima umum bahawa pembelian orang dalam ialah penunjuk positif, jadi syarikat yang mempunyai lebih banyak pembelian orang dalam akan mendapat kedudukan lebih tinggi daripada syarikat yang kurang pembelian orang dalam (atau malah jualan orang dalam).
Peratusan Saham Beredar yang Dibeli oleh Orang Dalam (Kedudukan)
0.000 %( )
8161 out of 11224Peratusan Saham Beredar yang Dibeli oleh Orang Dalam ialah jumlah bilangan saham yang dibeli oleh orang dalam tolak jumlah bilangan saham yang dijual oleh orang dalam dalam tempoh 90 hari terakhir, dibahagikan dengan jumlah saham beredar dan didarab dengan 100.
Carta Dagangan Dalaman
LadRx Corporation dagangan dalaman ditunjukkan dalam carta berikut. Orang dalam ialah pegawai, pengarah atau pelabur penting dalam syarikat. Secara umumnya adalah menyalahi undang-undang bagi orang dalam untuk membuat perdagangan dalam syarikat mereka berdasarkan maklumat material dan bukan awam. Ini tidak bermakna haram untuk mereka membuat sebarang perdagangan dalam syarikat mereka sendiri. Walau bagaimanapun, mereka mesti melaporkan semua dagangan kepada SEC melalui Borang 4.
Senarai Orang Dalam dan Metrik Keberuntungan
Jadual ini menunjukkan senarai orang dalam yang diketahui dan dijana secara automatik daripada pemfailan yang didedahkan kepada SEC. Sebagai tambahan kepada nama, gelaran terkini dan pengarah, pegawai, atau 10% jawatan pemilik, kami menyediakan pegangan yang didedahkan terkini. Selain itu, apabila boleh, kami menyediakan sejarah prestasi perdagangan untuk orang dalam. Sejarah prestasi perdagangan ialah purata wajaran prestasi transaksi pembelian pasaran terbuka sebenar yang dibuat oleh orang dalam. Untuk mendapatkan maklumat lanjut tentang cara ini dikira, tonton webinar YouTube ini.
See our leaderboard of most profitable insider traders.
| Orang dalam | Purata Keuntungan (%) | Saham Dimiliki |
Berpecah Dilaraskan |
|---|---|---|---|
| Earl W Brien Director - [D] | 590,247 | 590,247 | |
| John Y Caloz Chief Financial Officer - [O] | 31,792 | 5,299 | |
| Joel K Caldwell Director - [D] | 335,373 | 335,373 | |
| Anita J Chawla | 180,000 | ||
| Chawla Shanta M.D. Senior VP-Drug Development - [O] | 4,200 | 700 | |
| Cheryl Cohen | 180,000 | ||
| Eric Curtis | 0 |
| Orang dalam | Purata Keuntungan (%) | Saham Dimiliki |
Berpecah Dilaraskan |
|---|---|---|---|
| Louis Ignarro Director - [D] | 600,785 | 600,785 | |
| Steven A Kriegsman Chief Executive Officer, Director - [D] [O] | 3,668,038 | 3,668,038 | |
| Felix Kratz | 25,000 | ||
| Daniel J Levitt EVP and Chief Medical Officer - [O] | 161,036 | 26,839 | |
| Max Link Director - [D] | 260,305 | 43,384 | |
| Ben Levin GC/VP Legal Affairs/Secy - [O] | 33,578 | 5,596 | |
|
Scott Bradford Patterson
10% Owner -
|
4,577,605 | 762,934 |
| Orang dalam | Purata Keuntungan (%) | Saham Dimiliki |
Berpecah Dilaraskan |
|---|---|---|---|
| Joseph Rubinfeld | 180,000 | ||
| Eric Jay Selter Director - [D] | 54,288 | 9,048 | |
| Marvin R Selter Director - [D] | 253,193 | 42,199 | |
| Simpson Jennifer K. Director - [D] | 25,000 | 25,000 | |
| Stephen Snowdy | 300,000 | ||
| Olivia C Ware | 350,000 | ||
| Wennekamp Richard L. Director - [D] | 116,965 | 19,494 | |
| Douglas Scott Wieland | 150,000 |
Report errors via our new Insider Auditing Tool
Rekod Jejak Pembelian Orang Dalam - Analisis Keuntungan Jangka Pendek
Dalam bahagian ini, kami menganalisis keuntungan setiap pembelian orang dalam pasaran terbuka yang tidak dirancang yang dibuat dalam LADX / LadRx Corporation. Analisis ini membantu untuk memahami sama ada orang dalam secara konsisten menjana pulangan tidak normal dan patut diikuti. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah bersifat teori .
Jadual berikut menunjukkan pembelian pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.
Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras pecah.
Rekod Jejak Jualan Orang Dalam - Analisis Kerugian Jangka Pendek
Dalam bahagian ini, kami menganalisis pengelakan kerugian jangka pendek bagi setiap jualan dalaman pasaran terbuka yang tidak dirancang yang dibuat dalam LADX / LadRx Corporation. Corak pengelakan kerugian yang konsisten mungkin mencadangkan bahawa urus niaga jualan masa hadapan mungkin meramalkan penurunan harga. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah bersifat teori .
Jadual berikut menunjukkan jualan pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.
| Tarikh Dagangan | Orang dalam | Dilaporkan Saham |
Dilaporkan harga |
Dilaraskan Saham |
Dilaraskan harga |
Asas Kos | Hari ke Min |
Harga pada Min |
Kerugian Maks Dielakkan ($) |
Kerugian Maks Dielakkan (%) |
|---|---|---|---|---|---|---|---|
| Tiada dagangan pasaran terbuka yang tidak dirancang untuk orang dalam ini |
Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras pecah.
Sejarah Transaksi
Klik ikon pautan untuk melihat sejarah transaksi penuh. Transaksi yang dilaporkan sebagai sebahagian daripada pelan dagangan automatik 10b5-1 akan mempunyai X dalam lajur bertanda 10b-5.
| Fail Tarikh |
Dagangan Tarikh |
Borang | Orang dalam | Simbol Saham | Nama Sekuriti | Kod | Langsung | Harga Pelaksanaan |
Harga Unit |
Unit Berubah |
Nilai Berubah (1K) |
Baki Opsyen |
Baki Saham |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-01-12 | 2022-01-10 | 4 | Snowdy Stephen | CYTR | Stock Appreciation Right | D | 0.64 | 300,000 | 300,000 | |||||
| 2022-01-11 | 2021-12-15 | 4/A | Simpson Jennifer K. | CYTR | Stock Appreciation Right | D | 0.45 | 50,000 | 50,000 | |||||
| 2021-12-17 | 2021-12-15 | 4 | Simpson Jennifer K. | CYTR | Common Stock | D | 25,000 | 25,000 | ||||||
| 2020-08-20 | 2020-08-14 | 4 | Brien Earl W | CYTR | Stock Option (right to buy) | D | 0.26 | -150,000 | 300,000 | |||||
| 2020-08-20 | 2020-08-14 | 4 | Brien Earl W | CYTR | Common Stock, par value $0.001 per share | D | 0.2600 | 150,000 | 39 | 590,247 | ||||
| 2020-08-13 | 2020-08-07 | 4 | KRIEGSMAN STEVEN A | CYTR | Stock Option (right to buy) | D | 0.26 | -3,000,000 | 0 | |||||
| 2020-08-13 | 2020-08-07 | 4 | KRIEGSMAN STEVEN A | CYTR | Common Stock, par value $0.001 per share | D | 0.6700 | -1,164,179 | -780 | 3,668,038 | ||||
| 2020-08-13 | 2020-08-07 | 4 | KRIEGSMAN STEVEN A | CYTR | Common Stock, par value $0.001 per share | D | 0.2600 | 3,000,000 | 780 | 4,832,217 | ||||
| 2020-08-13 | 2020-08-07 | 4 | Caldwell Joel K | CYTR | Stock Option (right to buy) | D | 0.26 | -450,000 | 0 | |||||
| 2020-08-13 | 2020-08-07 | 4 | Caldwell Joel K | CYTR | Common Stock, par value $0.001 per share | D | 0.6700 | -174,627 | -117 | 335,373 | ||||
| 2020-08-13 | 2020-08-07 | 4 | Caldwell Joel K | CYTR | Common Stock, par value $0.001 per share | D | 0.2600 | 450,000 | 117 | 510,000 | ||||
| 2020-08-13 | 2020-08-07 | 4 | IGNARRO LOUIS | CYTR | Stock Option (right to buy) | D | 0.26 | -700,000 | 0 | |||||
| 2020-08-13 | 2020-08-07 | 4 | IGNARRO LOUIS | CYTR | Common Stock, par value $0.001 per share | D | 0.6700 | -271,642 | -182 | 600,785 | ||||
| 2020-08-13 | 2020-08-07 | 4 | IGNARRO LOUIS | CYTR | Common Stock, par value $0.001 per share | D | 0.2600 | 700,000 | 182 | 872,427 | ||||
| 2019-12-17 | 2019-12-13 | 4 | Brien Earl W | CYTR | Stock option (right to buy) | D | 0.26 | 450,000 | 450,000 | |||||
| 2019-12-17 | 2019-12-13 | 4 | Caldwell Joel K | CYTR | Stock Options (right to buy) | D | 0.26 | 450,000 | 450,000 | |||||
| 2019-12-17 | 2019-12-13 | 4 | CALOZ JOHN Y | CYTR | Stock Option (right to buy) | D | 0.26 | 350,000 | 350,000 | |||||
| 2019-12-17 | 2019-12-13 | 4 | IGNARRO LOUIS | CYTR | Stock Option (right to buy) | D | 0.26 | 700,000 | 700,000 | |||||
| 2019-12-17 | 2019-12-13 | 4 | KRIEGSMAN STEVEN A | CYTR | Stock Option (right to buy) | D | 0.26 | 3,000,000 | 3,000,000 | |||||
| 2018-01-02 | 2017-12-15 | 4 | Kratz Felix | CYTR | Stock Option (right to buy) | D | 1.75 | 25,000 | 25,000 | |||||
| 2017-12-19 | 2017-12-15 | 4 | KRIEGSMAN STEVEN A | CYTR | Stock Option (right to buy) | D | 1.75 | 208,334 | 208,334 | |||||
| 2017-12-19 | 2017-12-15 | 4 | KRIEGSMAN STEVEN A | CYTR | CytRx Common Stock | D | 1.7500 | 387,597 | 678 | 387,597 | ||||
| 2017-12-19 | 2017-12-15 | 4 | Brien Earl W | CYTR | Stock option (right to buy) | D | 1.75 | 70,000 | 70,000 | |||||
| 2017-12-19 | 2017-12-15 | 4 | Caldwell Joel K | CYTR | Stock Options (right to buy) | D | 1.75 | 30,000 | 30,000 | |||||
| 2017-12-19 | 2017-12-15 | 4 | CALOZ JOHN Y | CYTR | Stock Option (right to buy) | D | 1.75 | 58,334 | 58,334 | |||||
| 2017-12-19 | 2017-12-15 | 4 | IGNARRO LOUIS | CYTR | Stock Option (right to buy) | D | 1.75 | 30,000 | 30,000 | |||||
| 2017-09-06 | 2017-07-12 | 4 | Caldwell Joel K | CYTR | Stock Options (right to buy) | D | 0.67 | 180,000 | 180,000 | |||||
| 2017-06-20 | 3 | Chawla Shanta M.D. | CYTR | CytRx Common Stock | D | 4,200 | ||||||||
| 2017-06-20 | 3 | Chawla Shanta M.D. | CYTR | CytRx Common Stock | D | 4,200 | ||||||||
| 2016-12-20 | 2016-12-15 | 4 | KRIEGSMAN STEVEN A | CYTR | Stock Option (right to buy) | D | 0.43 | 1,250,000 | 1,250,000 | |||||
| 2016-12-20 | 2016-12-15 | 4 | KRIEGSMAN STEVEN A | CYTR | Common Stock | D | 0.4300 | 2,325,581 | 1,000 | 2,325,581 | ||||
| 2016-12-19 | 2016-12-15 | 4 | Brien Earl W | CYTR | Stock Option (right to buy) | D | 0.43 | 180,000 | 180,000 | |||||
| 2016-12-19 | 2016-12-15 | 4 | Chawla Anita J | CYTR | Stock Option (right to buy) | D | 0.43 | 180,000 | 180,000 | |||||
| 2016-12-19 | 2016-12-15 | 4 | IGNARRO LOUIS | CYTR | Stock Option (right to buy) | D | 0.43 | 180,000 | 180,000 | |||||
| 2016-12-19 | 2016-12-15 | 4 | RUBINFELD JOSEPH | CYTR | Stock Option (right to buy) | D | 0.43 | 180,000 | 180,000 | |||||
| 2016-12-19 | 2016-12-15 | 4 | KRIEGSMAN STEVEN A | CYTR | Stock Option (right to buy) | D | 0.43 | 1,250,000 | 1,250,000 | |||||
| 2016-12-19 | 2016-12-15 | 4 | CALOZ JOHN Y | CYTR | Stock Option (right to buy) | D | 0.43 | 350,000 | 350,000 | |||||
| 2016-12-19 | 2016-12-15 | 4 | Wieland Douglas Scott | CYTR | Stock Option (right to buy) | D | 0.43 | 150,000 | 150,000 | |||||
| 2016-12-19 | 2016-12-15 | 4 | LEVITT DANIEL J | CYTR | Stock Option (right to buy) | D | 0.43 | 400,000 | 400,000 | |||||
| 2016-12-09 | 3/A | Brien Earl W | CYTR | CytRx Common Stock | D | 61,484 | ||||||||
| 2016-12-06 | 3 | Brien Earl W | CYTR | CytRx Common Stock | D | 120,000 | ||||||||
| 2016-12-06 | 3 | Brien Earl W | CYTR | CytRx Common Stock | D | 120,000 | ||||||||
| 2016-12-06 | 2016-12-02 | 4 | Brien Earl W | CYTR | Stock options (right to buy) | D | 0.52 | 180,000 | 180,000 | |||||
| 2016-01-14 | 2016-01-11 | 4 | Ware Olivia C | CYTR | Stock option (right to buy) | D | 2.15 | 350,000 | 350,000 | |||||
| 2015-12-17 | 2015-12-15 | 4 | IGNARRO LOUIS | CYTR | Stock Option (right to buy) | D | 2.44 | 180,000 | 180,000 | |||||
| 2015-12-17 | 2015-12-15 | 4 | SELTER ERIC JAY | CYTR | Stock Option (right to buy) | D | 2.44 | 180,000 | 180,000 | |||||
| 2015-12-17 | 2015-12-15 | 4 | Chawla Anita J | CYTR | Stock Option (right to buy) | D | 2.44 | 180,000 | 180,000 | |||||
| 2015-12-17 | 2015-12-15 | 4 | Cohen Cheryl | CYTR | Stock Option (right to buy) | D | 2.44 | 180,000 | 180,000 | |||||
| 2015-12-17 | 2015-12-15 | 4 | Wieland Douglas Scott | CYTR | Stock Option (right to buy) | D | 2.44 | 100,000 | 100,000 | |||||
| 2015-12-17 | 2015-12-15 | 4 | Levin Ben | CYTR | Stock Option (right to buy) | D | 2.44 | 300,000 | 300,000 | |||||
| 2015-12-17 | 2015-12-15 | 4 | LEVITT DANIEL J | CYTR | Stock Option (right to buy) | D | 2.44 | 500,000 | 500,000 | |||||
| 2015-12-17 | 2015-12-15 | 4 | CALOZ JOHN Y | CYTR | Stock Option (right to buy) | D | 2.44 | 300,000 | 300,000 | |||||
| 2015-12-17 | 2015-12-15 | 4 | RUBINFELD JOSEPH | CYTR | Stock Option (right to buy) | D | 2.44 | 180,000 | 180,000 | |||||
| 2015-12-17 | 2015-12-15 | 4 | KRIEGSMAN STEVEN A | CYTR | Stock Option (right to buy) | D | 2.44 | 1,000,000 | 1,000,000 | |||||
| 2015-05-04 | 3 | SELTER ERIC JAY | CYTR | CytRx Common Stock | D | 54,288 | ||||||||
| 2015-05-04 | 3 | SELTER ERIC JAY | CYTR | CytRx Common Stock | D | 54,288 | ||||||||
| 2014-12-17 | 2014-12-15 | 4 | Wieland Douglas Scott | CYTR | Stock Option (right to buy) | D | 2.15 | 200,000 | 200,000 | |||||
| 2014-12-17 | 2014-12-15 | 4 | CALOZ JOHN Y | CYTR | Stock Option | D | 2.15 | 200,000 | 200,000 | |||||
| 2014-12-17 | 2014-12-15 | 4 | Levin Ben | CYTR | Stock Option (right to buy) | D | 2.15 | 200,000 | 200,000 | |||||
| 2014-12-17 | 2014-12-15 | 4 | LEVITT DANIEL J | CYTR | Stock Option | D | 2.15 | 400,000 | 400,000 | |||||
| 2014-12-16 | 2014-12-15 | 4/A | IGNARRO LOUIS | CYTR | Stock Option (right to buy | D | 2.15 | 180,000 | 180,000 | |||||
| 2014-12-16 | 2014-12-15 | 4/A | RUBINFELD JOSEPH | CYTR | Stock option (right to buy) | D | 2.15 | 180,000 | 180,000 | |||||
| 2014-12-16 | 2014-12-15 | 4 | KRIEGSMAN STEVEN A | CYTR | Stock Option (right to buy) | D | 2.15 | 600,000 | 600,000 | |||||
| 2014-12-16 | 2014-12-15 | 4 | RUBINFELD JOSEPH | CYTR | Stock Option (right to buy) | D | 2.15 | 180,000 | 180,000 | |||||
| 2014-12-16 | 2014-12-15 | 4 | IGNARRO LOUIS | CYTR | Stock Option (right to buy | D | 2.15 | 180,000 | 180,000 | |||||
| 2014-12-16 | 2015-12-15 | 4 | Wennekamp Richard L. | CYTR | Stock Option (right to buy) | D | 2.15 | 180,000 | 180,000 | |||||
| 2014-01-28 | 2014-01-01 | 4/A | LEVITT DANIEL J | CYTR | Common Stock | D | 100,000 | 161,036 | ||||||
| 2014-01-10 | 2014-01-01 | 4/A | LEVITT DANIEL J | CYTR | Common Stock | D | 100,000 | 157,983 | ||||||
| 2014-01-03 | 2014-01-01 | 4/A | LEVITT DANIEL J | CYTR | Common Stock | D | 100,000 | 157,706 | ||||||
| 2014-01-03 | 2014-01-01 | 4 | LEVITT DANIEL J | CYTR | Common Stock | D | 100,000 | 214,286 | ||||||
| 2013-12-12 | 2013-12-10 | 4 | LINK MAX | CYTR | Stock Option (right to buy) | D | 2.39 | 180,000 | 180,000 | |||||
| 2013-12-12 | 2013-12-10 | 4 | IGNARRO LOUIS | CYTR | Stock Option (right to buy) | D | 2.39 | 180,000 | 180,000 | |||||
| 2013-12-12 | 2013-12-10 | 4 | RUBINFELD JOSEPH | CYTR | Stock Option (right to buy) | D | 2.39 | 180,000 | 180,000 | |||||
| 2013-12-12 | 2013-12-10 | 4 | Levin Ben | CYTR | Stock Option (right to buy) | D | 2.39 | 300,000 | 300,000 | |||||
| 2013-12-12 | 2013-12-10 | 4 | Wennekamp Richard L. | CYTR | Stock Option (right to buy) | D | 2.39 | 180,000 | 180,000 | |||||
| 2013-12-12 | 2013-12-10 | 4 | LEVITT DANIEL J | CYTR | Stock Option (right to buy) | D | 2.39 | 500,000 | 500,000 | |||||
| 2013-12-12 | 2013-12-10 | 4 | SELTER MARVIN R | CYTR | Stock Option (right to buy) | D | 2.39 | -180,000 | 0 | |||||
| 2013-12-12 | 2013-12-10 | 4 | SELTER MARVIN R | CYTR | Stock Option (right to buy) | D | 2.39 | 180,000 | 180,000 | |||||
| 2013-12-12 | 2013-12-10 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 2.4039 | -334,979 | -805 | 4,577,605 | ||||
| 2013-12-11 | 2013-12-10 | 4 | CALOZ JOHN Y | CYTR | Stock Option (right to buy) | D | 2.39 | 150,000 | 150,000 | |||||
| 2013-12-11 | 2013-12-10 | 4 | KRIEGSMAN STEVEN A | CYTR | Stock Option (right to buy) | D | 2.39 | 925,000 | 925,000 | |||||
| 2013-12-11 | 2013-12-10 | 4 | Wieland Douglas Scott | CYTR | Stock Option (right to buy) | D | 2.39 | 150,000 | 150,000 | |||||
| 2013-12-03 | 2013-12-03 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 2.3476 | 42,131 | 99 | 4,912,584 | ||||
| 2013-12-03 | 2013-12-02 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 2.3910 | 77,148 | 184 | 4,870,453 | ||||
| 2013-12-03 | 2013-11-29 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 2.4813 | 165,700 | 411 | 4,793,305 | ||||
| 2013-11-08 | 2013-11-07 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 2.0568 | 50,000 | 103 | 4,627,605 | ||||
| 2013-04-03 | 2013-04-01 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 2.7000 | 4,083 | 11 | 4,577,605 | ||||
| 2013-03-22 | 2013-03-20 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 2.6100 | 3,980 | 10 | 4,573,522 | ||||
| 2013-03-20 | 2013-03-20 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 2.5704 | 8,420 | 22 | 4,569,542 | ||||
| 2013-03-20 | 2013-03-19 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 2.5795 | 24,100 | 62 | 4,561,122 | ||||
| 2013-03-20 | 2013-03-18 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 2.5556 | 3,000 | 8 | 4,537,022 | ||||
| 2013-03-14 | 2013-03-13 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 2.5199 | 360 | 1 | 4,534,022 | ||||
| 2013-03-14 | 2013-03-11 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 2.6680 | 55,000 | 147 | 4,533,662 | ||||
| 2013-03-12 | 2013-03-08 | 4 | KRIEGSMAN STEVEN A | CYTR | Stock Option (right to buy) | D | 2.46 | 74,176 | 74,176 | |||||
| 2013-01-07 | 2012-12-31 | 4/A | LEVITT DANIEL J | CYTR | Common Stock | D | 100,000 | 114,286 | ||||||
| 2013-01-02 | 2012-12-31 | 4 | LEVITT DANIEL J | CYTR | Common Stock | D | 100,000 | 200,000 | ||||||
| 2012-12-11 | 2012-12-10 | 4/A | CALOZ JOHN Y | CYTR | Stock Option (right to buy) | D | 1.83 | 100,000 | 100,000 | |||||
| 2012-12-11 | 2012-12-10 | 4 | KRIEGSMAN STEVEN A | 4wa@gwgz | Stock Option (right to buy) | D | 1.83 | 500,000 | 500,000 | |||||
| 2012-12-11 | 2012-12-10 | 4 | Levin Ben | CYTR | Stock Option (right to buy) | D | 1.83 | 100,000 | 100,000 | |||||
| 2012-12-11 | 2012-12-10 | 4 | CALOZ JOHN Y | CYTR | Stock Option (right to buy) | D | 1.83 | 100,000 | 100,000 | |||||
| 2012-12-11 | 2012-12-10 | 4 | Wieland Douglas Scott | CYTR | Stock Option(right to buy) | D | 1.83 | 100,000 | 100,000 | |||||
| 2012-12-11 | 2012-12-10 | 4 | SELTER MARVIN R | CYTR | Stock Option (right to buy) | D | 1.83 | -100,000 | 0 | |||||
| 2012-12-11 | 2012-12-10 | 4 | SELTER MARVIN R | CYTR | Stock Option (right to buy) | D | 1.83 | 100,000 | 100,000 | |||||
| 2012-12-11 | 2012-12-10 | 4 | LINK MAX | CYTR | Stock Option (right to buy) | D | 1.83 | 100,000 | 100,000 | |||||
| 2012-12-11 | 2012-12-10 | 4 | Wennekamp Richard L. | CYTR | Stock Option (right to buy) | D | 1.83 | 100,000 | 100,000 | |||||
| 2012-12-11 | 2012-12-10 | 4 | IGNARRO LOUIS | CYTR | Stock Option (right to buy) | D | 1.83 | 100,000 | 100,000 | |||||
| 2012-12-11 | 2012-12-10 | 4 | RUBINFELD JOSEPH | CYTR | Stock Option (right to buy) | D | 1.83 | 30,000 | 30,000 | |||||
| 2012-12-11 | 2012-12-10 | 4 | RUBINFELD JOSEPH | CYTR | Stock Option (right to buy) | D | 1.83 | 100,000 | 100,000 | |||||
| 2012-12-11 | 2012-12-10 | 4 | SELTER MARVIN R | CYTR | Stock Option (right to buy) | D | 8.05 | -7,142 | 0 | |||||
| 2012-12-11 | 2012-12-10 | 4 | SELTER MARVIN R | CYTR | Stock Option (right to buy) | D | 2.80 | -7,142 | 0 | |||||
| 2012-12-11 | 2012-12-10 | 4 | SELTER MARVIN R | CYTR | Stock Option (right to buy) | D | 5.04 | -7,142 | 0 | |||||
| 2012-12-11 | 2012-12-10 | 4 | SELTER MARVIN R | CYTR | Stock Option (right to buy) | D | 5.46 | -7,142 | 0 | |||||
| 2012-12-11 | 2012-12-10 | 4 | SELTER MARVIN R | CYTR | Stock Option (right to buy) | D | 7.77 | -3,572 | 0 | |||||
| 2012-12-11 | 2012-12-10 | 4 | SELTER MARVIN R | CYTR | Stock Option (right to buy) | D | 3.99 | -3,572 | 0 | |||||
| 2012-12-11 | 2012-12-10 | 4 | SELTER MARVIN R | CYTR | Stock Option (right to buy) | D | 23.31 | -3,572 | 0 | |||||
| 2012-12-11 | 2012-12-10 | 4 | SELTER MARVIN R | CYTR | Stock Option (right to buy) | D | 5.88 | -2,142 | 0 | |||||
| 2012-12-11 | 2012-12-10 | 4 | SELTER MARVIN R | CYTR | Stock Option (right to buy) | D | 8.33 | -714 | 0 | |||||
| 2012-12-11 | 2012-12-10 | 4 | SELTER MARVIN R | CYTR | Stock Option (right to buy) | D | 16.45 | -1,428 | 0 | |||||
| 2012-12-11 | 2012-12-10 | 4 | SELTER MARVIN R | CYTR | Stock Option (right to buy) | D | 8.40 | -1,428 | 0 | |||||
| 2012-10-23 | 2012-10-22 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 2.5072 | 115,000 | 288 | 4,478,662 | ||||
| 2012-10-23 | 2012-10-19 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 2.5129 | 65,000 | 163 | 4,363,662 | ||||
| 2012-10-18 | 2012-10-18 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 2.5000 | 1,200,000 | 3,000 | 4,298,662 | ||||
| 2012-06-28 | 2012-06-28 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 4.9020 | 16,000 | 78 | 3,098,662 | ||||
| 2012-06-28 | 2012-06-27 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 5.2316 | 15,824 | 83 | 3,082,662 | ||||
| 2012-06-28 | 2012-06-26 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 5.3175 | 13,000 | 69 | 3,066,838 | ||||
| 2012-06-25 | 2012-06-25 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 5.1634 | 17,835 | 92 | 3,053,838 | ||||
| 2012-06-25 | 2012-06-22 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 4.7411 | 5,334 | 25 | 3,036,003 | ||||
| 2012-06-25 | 2012-06-21 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 4.6109 | 4,293 | 20 | 3,030,669 | ||||
| 2012-06-20 | 2012-06-20 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 4.6475 | 7,283 | 34 | 3,026,376 | ||||
| 2012-06-20 | 2012-06-19 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 4.4796 | 9,210 | 41 | 3,019,093 | ||||
| 2012-06-20 | 2012-06-18 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 4.2470 | 4,621 | 20 | 3,009,883 | ||||
| 2012-06-18 | 2012-06-15 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 3.8927 | 3,558 | 14 | 3,005,262 | ||||
| 2012-06-18 | 2012-06-14 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 3.8323 | 10,976 | 42 | 3,001,704 | ||||
| 2012-06-14 | 2012-06-13 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 3.8817 | 14,176 | 55 | 2,990,728 | ||||
| 2012-06-14 | 2012-06-12 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 3.8015 | 5,594 | 21 | 2,976,552 | ||||
| 2012-06-12 | 2012-06-11 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 3.8042 | 23,399 | 89 | 2,970,958 | ||||
| 2012-06-12 | 2012-06-08 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 3.8010 | 20,933 | 80 | 2,947,559 | ||||
| 2012-06-07 | 2012-06-07 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 3.8457 | 53,635 | 206 | 2,926,626 | ||||
| 2012-06-07 | 2012-06-06 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 3.9659 | 24,894 | 99 | 2,872,991 | ||||
| 2012-06-07 | 2012-06-05 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 3.8513 | 66,704 | 257 | 2,848,097 | ||||
| 2012-06-04 | 2012-06-04 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 3.5254 | 221,000 | 779 | 2,863,292 | ||||
| 2012-06-04 | 2012-06-01 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 3.7364 | 86,696 | 324 | 2,642,292 | ||||
| 2012-06-04 | 2012-05-31 | 4 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 3.8324 | 190,200 | 729 | 2,555,596 | ||||
| 2012-05-31 | 3 | Patterson Scott Bradford By Spouse | CYTR | CYTR Common Stock, $0.01 par value per share | I | 81,899 | ||||||||
| 2012-05-31 | 3 | Patterson Scott Bradford | CYTR | CYTR Common Stock, $0.01 par value per share | D | 2,283,497 | ||||||||
| 2012-05-15 | 2012-05-14 | 4 | IGNARRO LOUIS | CYTR | Stock Option (right to buy) | D | 0.40 | 50,000 | 50,000 | |||||
| 2012-05-15 | 2012-05-14 | 4 | LINK MAX | CYTR | Stock Option (right to buy) | D | 0.40 | 50,000 | 50,000 | |||||
| 2012-05-15 | 2012-05-14 | 4 | RUBINFELD JOSEPH | CYTR | Stock Option (right to buy) | D | 0.40 | 50,000 | 50,000 | |||||
| 2012-05-15 | 2012-05-14 | 4 | SELTER MARVIN R | CYTR | Stock Option (right to buy) | D | 0.40 | 50,000 | 50,000 | |||||
| 2012-05-15 | 2012-05-14 | 4 | Wennekamp Richard L. | CYTR | Stock Option (right to buy) | D | 0.40 | 50,000 | 50,000 | |||||
| 2012-02-24 | 2012-02-23 | 4 | KRIEGSMAN STEVEN A | CYTR | Common Stock | D | 0.3265 | 105,517 | 34 | 4,179,776 | ||||
| 2012-02-24 | 2012-02-22 | 4 | KRIEGSMAN STEVEN A | CYTR | Common Stock | D | 0.3093 | 53,159 | 16 | 4,074,259 | ||||
| 2012-02-24 | 2012-02-23 | 4 | Levin Ben | CYTR | Common Stock | D | 0.3265 | 22,329 | 7 | 33,578 | ||||
| 2012-02-24 | 2012-02-22 | 4 | Levin Ben | CYTR | Common Stock | D | 0.3093 | 11,249 | 3 | 11,249 | ||||
| 2012-02-24 | 2012-02-22 | 4 | LEVITT DANIEL J | CYTR | Common Stock | D | 0.2875 | 100,000 | 29 | 100,000 | ||||
| 2012-02-24 | 2012-02-23 | 4 | Wennekamp Richard L. | CYTR | Common Stock | D | 0.3265 | 74,455 | 24 | 116,965 | ||||
| 2012-02-24 | 2012-02-22 | 4 | Wennekamp Richard L. | CYTR | Common Stock | D | 0.3093 | 37,510 | 12 | 42,510 | ||||
| 2012-02-24 | 2012-02-22 | 4 | SELTER MARVIN R | CYTR | Common Stock | D | 0.3120 | 100,000 | 31 | 253,193 | ||||
| 2012-02-24 | 2012-02-23 | 4 | CALOZ JOHN Y | CYTR | Common Stock | D | 0.3265 | 21,141 | 7 | 31,792 | ||||
| 2012-02-24 | 2012-02-22 | 4 | CALOZ JOHN Y | CYTR | Common Stock | D | 0.3093 | 10,651 | 3 | 10,651 | ||||
| 2012-02-24 | 2012-02-23 | 4 | LINK MAX | CYTR | Common Stock | D | 0.3265 | 136,540 | 45 | 260,305 | ||||
| 2012-02-24 | 2012-02-22 | 4 | LINK MAX | CYTR | Common Stock | D | 0.3093 | 68,789 | 21 | 123,765 |
P
Pasaran terbuka atau pembelian persendirian sekuriti bukan derivatif atau derivatif
S
Pasaran terbuka atau jualan persendirian sekuriti bukan derivatif atau derivatif
A
Pemberian, penganugerahan atau pemerolehan lain sekuriti daripada syarikat (seperti opsyen)
C
Penukaran derivatif
D
Penjualan atau pemindahan sekuriti kembali kepada syarikat
F
Pembayaran harga pelaksanaan atau liabiliti cukai menggunakan sebahagian daripada sekuriti yang diterima daripada syarikat
G
Hadiah sekuriti oleh atau kepada orang dalam
K
Swap ekuiti dan urus niaga lindung nilai yang serupa
M
Pelaksanaan atau penukaran sekuriti derivatif yang diterima daripada syarikat (seperti opsyen)
V
Transaksi dilaporkan secara sukarela pada Borang 4
J
Lain-lain (disertai dengan nota kaki yang menerangkan transaksi)
